These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9044323)
21. The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease. Zeier M; Geberth S; Gonzalo A; Chauveau D; Grünfeld JP; Ritz E J Am Soc Nephrol; 1992 Nov; 3(5):1119-23. PubMed ID: 1482752 [TBL] [Abstract][Full Text] [Related]
22. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease. Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477 [TBL] [Abstract][Full Text] [Related]
23. Outcome of Kidney Transplant in Patients with Polycystic Kidney Disease: A Single-Center Study in Tunisia. Barbouch S; Hajji M; Hedri H; El Younsi F; Ben Hamida F; Bacha MM; Ounissi M; Abderrahim E; Ben Abdallah T Exp Clin Transplant; 2017 Feb; 15(Suppl 1):196-199. PubMed ID: 28260467 [TBL] [Abstract][Full Text] [Related]
24. Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease. Orskov B; Christensen KB; Feldt-Rasmussen B; Strandgaard S Kidney Int; 2012 May; 81(9):919-24. PubMed ID: 22297678 [TBL] [Abstract][Full Text] [Related]
25. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US. Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357 [TBL] [Abstract][Full Text] [Related]
26. Chronic renal failure in a patient with Sotos syndrome due to autosomal dominant polycystic kidney disease. Cefle K; Yildiz A; Palanduz S; Ozturk S; Ozbey N; Kylyçaslan I; Colakoglu S; Balci C Int J Clin Pract; 2002 May; 56(4):316-8. PubMed ID: 12074220 [TBL] [Abstract][Full Text] [Related]
27. Genetic linkage analysis, clinical features and prognosis of autosomal dominant polycystic kidney disease in Northern Ireland. Wright GD; Hughes AE; Larkin KA; Doherty CC; Nevin NC Q J Med; 1993 Jul; 86(7):459-63. PubMed ID: 8210302 [TBL] [Abstract][Full Text] [Related]
28. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. Johnson AM; Gabow PA J Am Soc Nephrol; 1997 Oct; 8(10):1560-7. PubMed ID: 9335384 [TBL] [Abstract][Full Text] [Related]
29. Overview of autosomal dominant polycystic kidney disease in the south of Spain. Morales García AI; Martínez Atienza M; García Valverde M; Fontes Jimenez J; Martínez Morcillo A; Esteban de la Rosa MA; de Diego Fernández P; García González M; Fernández Castillo R; Argüelles Toledo I; Bravo Soto JA; Esteban de la Rosa R; Nefrologia (Engl Ed); 2018; 38(2):190-196. PubMed ID: 29471960 [TBL] [Abstract][Full Text] [Related]
30. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. Parfrey PS; Bear JC; Morgan J; Cramer BC; McManamon PJ; Gault MH; Churchill DN; Singh M; Hewitt R; Somlo S N Engl J Med; 1990 Oct; 323(16):1085-90. PubMed ID: 2215575 [TBL] [Abstract][Full Text] [Related]
31. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease. Lee KB; Kim UK; Lee CC J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692 [TBL] [Abstract][Full Text] [Related]
32. Autosomal dominant polycystic kidney disease: pathophysiology and treatment. McCarthy S; McMullen M ANNA J; 1997 Feb; 24(1):45-51; quiz 52-3. PubMed ID: 9146123 [TBL] [Abstract][Full Text] [Related]
33. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Torra R; Badenas C; Pérez-Oller L; Luis J; Millán S; Nicolau C; Oppenheimer F; Milà M; Darnell A Am J Kidney Dis; 2000 Oct; 36(4):728-34. PubMed ID: 11007674 [TBL] [Abstract][Full Text] [Related]
34. Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney disease. Haseebuddin M; Tanagho YS; Millar M; Roytman T; Chen C; Clayman RV; Miller B; Desai A; Benway B; Bhayani S; Figenshau RS J Urol; 2012 Oct; 188(4):1239-44. PubMed ID: 22902029 [TBL] [Abstract][Full Text] [Related]
35. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure. Shaw C; Simms RJ; Pitcher D; Sandford R Nephrol Dial Transplant; 2014 Oct; 29(10):1910-8. PubMed ID: 24737444 [TBL] [Abstract][Full Text] [Related]
36. Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases? Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B Nephrology (Carlton); 2018 Jan; 23(1):31-36. PubMed ID: 27653449 [TBL] [Abstract][Full Text] [Related]
38. [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region]. Simon P; Le Goff JY; Ang KS; Charasse C; Le Cacheux P; Cam G Nephrologie; 1996; 17(2):123-30. PubMed ID: 8838759 [TBL] [Abstract][Full Text] [Related]
39. Erythropoietin-producing renal cell carcinoma arising from autosomal dominant polycystic kidney disease. Hama Y; Kaji T; Ito K; Hayakawa M; Tobe M; Kosuda S Br J Radiol; 2005 Mar; 78(927):269-71. PubMed ID: 15730996 [TBL] [Abstract][Full Text] [Related]
40. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease. Nowak KL; Cadnapaphornchai MA; Chonchol MB; Schrier RW; Gitomer B Am J Nephrol; 2016; 44(3):171-8. PubMed ID: 27548646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]